Protagonist Therapeutics
PTGX
PTGX
70 hedge funds and large institutions have $103M invested in Protagonist Therapeutics in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.23% less ownership
Funds ownership: 57.79% → 56.56% (-1.2%)
55% less capital invested
Capital invested by funds: $226M → $103M (-$123M)
Holders
70
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.31M | |
| 2 | +$1.66M | |
| 3 | +$1.23M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.17M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.14M |
Top Sellers
| 1 | -$9.07M | |
| 2 | -$5.72M | |
| 3 | -$4.68M | |
| 4 |
AIC
AWM Investment Company
New York
|
-$3.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.5M |